These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 2420778

  • 1. Pulmonary vascular tone is increased by a voltage-dependent calcium channel potentiator.
    Tolins M, Weir EK, Chesler E, Nelson DP, From AH.
    J Appl Physiol (1985); 1986 Mar; 60(3):942-8. PubMed ID: 2420778
    [Abstract] [Full Text] [Related]

  • 2. BAY K 8644 potentiates and A23187 inhibits hypoxic vasoconstriction in rat lungs.
    McMurtry IF.
    Am J Physiol; 1985 Oct; 249(4 Pt 2):H741-6. PubMed ID: 2413777
    [Abstract] [Full Text] [Related]

  • 3. Segmental vascular responses to voltage-gated calcium channel potentiation in rat lung.
    Bhattacharya S, Bhattacharya J.
    J Appl Physiol (1985); 1992 Aug; 73(2):657-63. PubMed ID: 1383184
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potassium channels modulate hypoxic pulmonary vasoconstriction.
    Barman SA.
    Am J Physiol; 1998 Jul; 275(1):L64-70. PubMed ID: 9688936
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bay K8644 differentiates between potential and receptor operated Ca2+ channels.
    Yamamoto H, Hwang O, Van Breemen C.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):555-7. PubMed ID: 6208039
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
    Erdemli O, Hao Q, Cai B, Lippton HL, Hyman A.
    Arch Int Pharmacodyn Ther; 1994 Jul 20; 328(2):165-79. PubMed ID: 7535994
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of nisoldipine on vascular resistance and vasoconstrictor responses in cats.
    Armstead WM, Lippton HL, Hyman AL, Kadowitz PJ.
    Am J Physiol; 1987 Apr 20; 252(4 Pt 2):H816-25. PubMed ID: 2436491
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective enhancement of angiotensin II- and potassium-stimulated aldosterone secretion by the calcium channel agonist BAY K 8644.
    Hausdorff WP, Aguilera G, Catt KJ.
    Endocrinology; 1986 Feb 20; 118(2):869-74. PubMed ID: 2417828
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of the pressor effect of the calcium agonist, BAY k 8644, in the intact rat.
    Lefer AM, Whitney CC, Hock CE.
    Pharmacology; 1986 Feb 20; 32(4):181-9. PubMed ID: 2424034
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The calcium channel agonist, Bay K 8644, inhibits renin release from rat kidney cortical slices.
    Matsumura Y, Sasaki Y, Shinyama H, Morimoto S.
    Eur J Pharmacol; 1985 Nov 19; 117(3):369-72. PubMed ID: 2416580
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Similarity and dissimilarity of the vasoconstrictor effects of Bay K 8644 on coronary, femoral, mesenteric and renal circulations of dogs.
    Ishii K, Sato Y, Taira N.
    Br J Pharmacol; 1986 Jun 19; 88(2):369-77. PubMed ID: 2425879
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.